Cite
MMP-2, MMP-9 and their inhibitors TIMP-2 and TIMP-1 production by human monocytes in vitro in the presence of different forms of hydroxyapatite particles.
MLA
Laquerriere, Patrice, et al. “MMP-2, MMP-9 and Their Inhibitors TIMP-2 and TIMP-1 Production by Human Monocytes in Vitro in the Presence of Different Forms of Hydroxyapatite Particles.” Biomaterials, vol. 25, no. 13, June 2004, pp. 2515–24. EBSCOhost, https://doi.org/10.1016/j.biomaterials.2003.09.034.
APA
Laquerriere, P., Grandjean-Laquerriere, A., Addadi-Rebbah, S., Jallot, E., Laurent-Maquin, D., Frayssinet, P., & Guenounou, M. (2004). MMP-2, MMP-9 and their inhibitors TIMP-2 and TIMP-1 production by human monocytes in vitro in the presence of different forms of hydroxyapatite particles. Biomaterials, 25(13), 2515–2524. https://doi.org/10.1016/j.biomaterials.2003.09.034
Chicago
Laquerriere, Patrice, Alexia Grandjean-Laquerriere, Salima Addadi-Rebbah, Edouard Jallot, Dominique Laurent-Maquin, Patrick Frayssinet, and Moncef Guenounou. 2004. “MMP-2, MMP-9 and Their Inhibitors TIMP-2 and TIMP-1 Production by Human Monocytes in Vitro in the Presence of Different Forms of Hydroxyapatite Particles.” Biomaterials 25 (13): 2515–24. doi:10.1016/j.biomaterials.2003.09.034.